MSTN and obesity disorder: Myostatin (GDF-8), frequently elevated in obesity and early T2D, exerts potent anti-anabolic and anti-oxidative effects and signals through the SMAD (mothers against decapentaplegic homolog) family of transcription factors, particularly SMAD2/3 [49,50].